- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
AN2 Therapeutics Inc (ANTX)
Track today's live AN2 Therapeutics (ANTX) share price, performance and key data on this page with our current NASDAQ:ANTX stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the AN2 Therapeutics share price on the NASDAQ exchange. Use the dropdown to switch exchange for the ANTX share price, head to our technical summary section, which provides analysis on AN2 Therapeutics share price buy/sell indicators using real-time data (or discuss the AN2 Therapeutics (ANTX) stock price today with other investors in the AN2 Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ANTX share price (ISIN: US0373261058) to enhance your trading decisions with our free investment tools and resources.
What Is the AN2 Therapeutics Inc Share Price Today?
The AN2 Therapeutics share price today is 5.870.
What Is the Stock Symbol for AN2 Therapeutics Inc
The stock symbol (or 'ticker') for AN2 Therapeutics Inc is "ANTX."
What Stock Exchange Does AN2 Therapeutics Inc Trade On?
AN2 Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is AN2 Therapeutics Inc a Good Stock to Buy?
Determining whether AN2 Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ANTX share price (ISIN: US0373261058) to enhance your trading decisions with our free investment tools and resources.
What Is the AN2 Therapeutics Inc Share Price Today?
The AN2 Therapeutics share price today is 5.870.
What Is the Stock Symbol for AN2 Therapeutics Inc
The stock symbol (or 'ticker') for AN2 Therapeutics Inc is "ANTX."
What Stock Exchange Does AN2 Therapeutics Inc Trade On?
AN2 Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is AN2 Therapeutics Inc a Good Stock to Buy?
Determining whether AN2 Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.800
6.090
52 wk Range
1.000
6.910
Earnings results expected today
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.8006.090
52 wk Range
1.0006.910
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ANTX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
9.000
Upside
+53.32%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
AN2 Therapeutics receives Investment Bank Analyst Rating Update- Investing.com
Pro
Form 13G AN2 Therapeutics For: 15 May- Investing.com
Form 4 AN2 Therapeutics Inc For: 10 July- Investing.com
- AN2 Therapeutics receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 4 AN2 Therapeutics Inc For: 10 July
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 9.000
(+53.32% Upside)
Earnings
Latest Release
11/08/2026
EPS / Forecast
-0.18 / -0.23
Revenue / Forecast
-- / --
Compare ANTX to Peers and Sector
Metrics to compare | ANTX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipANTXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.1x | −0.3x | −0.4x | |
PEG Ratio | −0.23 | −0.09 | 0.00 | |
Price/Book | 2.6x | 1.1x | 2.6x | |
Price / LTM Sales | - | 0.9x | 3.1x | |
Upside (Analyst Target) | 52.3% | 87.6% | 48.2% | |
Fair Value Upside | Unlock | 6.9% | 5.8% | Unlock |
AN2 Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics. The company’s initial candidate includes epetraborole, which is phase 3 clinical trial as a once-daily oral treatment for patients with non-tuberculous mycobacterial lung disease, as well as studying for the treatment of acute melioidosis. It also develops AN2-502998 (AN15368), an investigational, boron-based small molecule in development for the treatment of chronic Chagas disease that is in preclinical trials; and has various research programs targeting the development of novel compounds in oncology and infectious disease based on its boron chemistry platform. It has a license agreement with Anacor Pharmaceuticals, Inc. to use, develop, manufacture, commercialize compounds and products, including epetraborole for the treatment, diagnosis, or prevention of various human diseases; and Brii Biosciences Limited to research, develop, manufacture, and commercialize compounds and products comprising epetraborole in China, Hong Kong, Taiwan, and Macau for the diagnosis, treatment, and prevention of human diseases; and GSK plc for the development of new therapies for TB. AN2 Therapeutics, Inc. was incorporated in 2017 and is headquartered in Menlo Park, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the AN2 Therapeutics (NASDAQ: ANTX) Share Price Today?
The AN2 Therapeutics stock price today is 5.870 USD.
What Stock Exchange Does AN2 Therapeutics (ANTX) Trade On?
AN2 Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for AN2 Therapeutics?
The stock symbol (also called a 'ticker') for AN2 Therapeutics is "ANTX."
What Is the Current AN2 Therapeutics Market Capitalisation?
As of today, AN2 Therapeutics (NASDAQ: ANTX) market cap is 212.860M USD.
What Is AN2 Therapeutics's (ANTX) Earnings Per Share (TTM)?
The AN2 Therapeutics EPS is currently -1.107 (Trailing Twelve Months).
When Is the Next AN2 Therapeutics Earnings Date?
AN2 Therapeutics's next earnings report will be released on 11/08/2026.
Is ANTX a Buy or Sell From a Technical Analyst Perspective?
Based on today's AN2 Therapeutics moving averages and other technical indicators, the daily buy/sell signal for ANTX stock is Strong Buy.
How Many Times Has AN2 Therapeutics Stock Split?
AN2 Therapeutics has split 0 times. (See the ANTX stock split history page for full effective split date and price information.)
What is the current trading status of AN2 Therapeutics (NASDAQ: ANTX)?
As of 11/08/2026, AN2 Therapeutics (ANTX) is trading at a share price of 5.870 USD, with a previous close of 5.910 USD. The stock has fluctuated within a day range of 5.800 USD to 6.090 USD, while its 52-week range spans from 1.000 USD to 6.910 USD.
What Is AN2 Therapeutics (ANTX) Price Target According to Analysts?
The average 12-month price target for AN2 Therapeutics is 9.000 USD, with a high estimate of 9 USD and a low estimate of 9 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +53.32% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.